- New
Tirzepatide 30 mg · Lyophilised vial
GLP-1/GIP dual agonist for appetite and glucose.
HGH fragment studied for fat metabolism.
HGH fragment studied for fat metabolism. Active: AOD-9604. Strength: 10 mg. Form: Lyophilised vial. Route: Subcutaneous. Class: HGH fragment. Supplied under the Hexal-OZ line. Priced in AUD; paid in crypto via BTCPay (XMR preferred, BTC secondary).
Data sheet
GLP-1/GIP dual agonist for appetite and glucose.
The go-to GH-pulse stack in one vial.
Immune-modulating thymic peptide.
Libido and arousal research peptide.
Focus, memory and neuroprotection research peptide.
Body Protection Compound. Tissue and gut repair.
Long-arginine IGF-1 for local growth and recovery.
Triple-agonist for appetite and body recomposition.
GHRH analog targeting visceral fat and GH output.
191-aa recombinant growth hormone. Cold-chain kit.
Systemic recovery and flexibility. Pairs with BPC-157.
Short-acting GHRH for clean GH pulses.
Skin, collagen and wound-healing copper peptide.
Cellular energy and longevity coenzyme.